<DOC>
	<DOCNO>NCT02907268</DOCNO>
	<brief_summary>A 16-week single-blind , split-face , randomize study . Each patient serve control , receive onabotulinumtoxinA abobotulinumtoxinA randomize either leave right side face . Patients receive intradermal BTXA injection week 0 intramuscular BTXA injection week 2 . The objective examine effectiveness intradermal botulinum toxin type A ( BTXA ) injection improve skin texture midface lift reduce pore size sebum production , well investigate difference effectiveness onabotulinumtoxinA abobotulinumtoxinA use intradermal intramuscular injection method .</brief_summary>
	<brief_title>Botulinum Toxin A Single Blind Split-Face Randomized Pilot Study</brief_title>
	<detailed_description />
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Female subject age 35 65 year ( inclusive ) exhibit static wrinkle follow area : glabella ( forehead frown ) , periorbital area ( crows foot ) . Static wrinkle additional area face also acceptable . Subject willing maintain skin care regimen throughout study already maintain skin care regime 4 week prior baseline . The subject able comply study procedure instruction commit attend study visit within give timeline . Subject judge good candidate study nurse upon identification dynamic and/or static wrinkle area movement , moderate amount skin laxity . Subject willing use contraception A sign informed consent form subject able give consent , prior study procedure perform . Sensitivity and/or contraindication botulinum toxin A ingredient contain botulinum toxin A product . Any medical condition , opinion investigator , would interfere safety study procedure ( e.g . autoimmune disease , history severe allergy , hypertrophic scar , immunotherapeutic treatment , inflammatory infectious complaint injection site , unable give consent ) Treatment botulinum toxin A injection neck face within 1 year baseline treatment Treatment facial filler less 1 year prior baseline Females childbearing potential pregnant , breastfeed plan get pregnant course study . Previous treatment Lasers , Ultrasound Technology Radio Frequency face and/or neck within 1 year prior baseline . Treatment Accutane ( isotretinoin ) oral medication acne 1 year prior baseline . The use antiaging product contain retinol Known allergy cow 's milk protein</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>botulinum toxin type A , intradermal</keyword>
</DOC>